Orion Oyj (ORINF)
USD 48.65
(0.0%)
USD 48.65
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.43 Billion EUR | -4.32% |
| 2022 | 1.5 Billion USD | 18.75% |
| 2021 | 1.26 Billion EUR | -7.24% |
| 2020 | 1.36 Billion EUR | 17.41% |
| 2019 | 1.16 Billion EUR | 1.38% |
| 2018 | 1.14 Billion EUR | 8.64% |
| 2017 | 1.05 Billion EUR | -0.7% |
| 2016 | 1.06 Billion EUR | -6.58% |
| 2015 | 1.13 Billion EUR | 13.61% |
| 2014 | 1 Billion EUR | 2.3% |
| 2013 | 979 Million EUR | 17.15% |
| 2012 | 835.7 Million EUR | 7.26% |
| 2011 | 779.1 Million EUR | 4.47% |
| 2010 | 745.8 Million EUR | 2.57% |
| 2009 | 727.1 Million EUR | 4.54% |
| 2008 | 695.5 Million EUR | 22.95% |
| 2007 | 565.7 Million EUR | -3.81% |
| 2006 | 588.1 Million EUR | -48.27% |
| 2005 | 1.13 Billion EUR | 0.11% |
| 2004 | 1.13 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.6 Billion EUR | 10.32% |
| 2024 Q2 | 1.45 Billion EUR | -0.24% |
| 2024 Q1 | 1.57 Billion EUR | 1.54% |
| 2023 Q3 | 1.45 Billion USD | 1.67% |
| 2023 Q2 | 1.42 Billion USD | 1.85% |
| 2023 Q1 | 1.4 Billion USD | -12.96% |
| 2023 Q4 | 1.58 Billion EUR | 9.47% |
| 2023 FY | 1.43 Billion EUR | -4.32% |
| 2022 Q4 | 1.6 Billion USD | 4.75% |
| 2022 FY | 1.5 Billion USD | 18.75% |
| 2022 Q1 | 1.22 Billion EUR | 9.94% |
| 2022 Q2 | 1.33 Billion EUR | 8.74% |
| 2022 Q3 | 1.53 Billion EUR | 15.35% |
| 2021 Q2 | 1.23 Billion EUR | -11.37% |
| 2021 Q4 | 1.11 Billion EUR | 5.48% |
| 2021 Q3 | 1.05 Billion EUR | -14.49% |
| 2021 Q1 | 1.39 Billion EUR | 24.9% |
| 2021 FY | 1.26 Billion EUR | -7.24% |
| 2020 Q1 | 1.24 Billion EUR | 20.08% |
| 2020 FY | 1.36 Billion EUR | 17.41% |
| 2020 Q2 | 1.1 Billion EUR | -11.05% |
| 2020 Q3 | 1.1 Billion EUR | -0.53% |
| 2020 Q4 | 1.11 Billion EUR | 1.38% |
| 2019 FY | 1.16 Billion EUR | 1.38% |
| 2019 Q4 | 1.03 Billion EUR | 11.1% |
| 2019 Q2 | 898.4 Million EUR | -25.11% |
| 2019 Q3 | 932.2 Million EUR | 3.76% |
| 2019 Q1 | 1.19 Billion EUR | 4.62% |
| 2018 Q1 | 1.01 Billion EUR | -3.74% |
| 2018 FY | 1.14 Billion EUR | 8.64% |
| 2018 Q4 | 1.14 Billion EUR | 5.33% |
| 2018 Q3 | 1.08 Billion EUR | 1.47% |
| 2018 Q2 | 1.07 Billion EUR | 5.6% |
| 2017 Q1 | 937.3 Million EUR | -11.82% |
| 2017 FY | 1.05 Billion EUR | -0.7% |
| 2017 Q4 | 1.05 Billion EUR | 8.8% |
| 2017 Q3 | 970.1 Million EUR | 2.39% |
| 2017 Q2 | 947.5 Million EUR | 1.09% |
| 2016 Q1 | 1.08 Billion EUR | 3.87% |
| 2016 FY | 1.06 Billion EUR | -6.58% |
| 2016 Q4 | 1.06 Billion EUR | 6.44% |
| 2016 Q3 | 998.6 Million EUR | 6.72% |
| 2016 Q2 | 935.7 Million EUR | -13.99% |
| 2015 Q3 | 974 Million EUR | 3.17% |
| 2015 FY | 1.13 Billion EUR | 13.61% |
| 2015 Q4 | 1.04 Billion EUR | 7.54% |
| 2015 Q2 | 944.1 Million EUR | -11.79% |
| 2015 Q1 | 1.07 Billion EUR | 6.87% |
| 2014 Q2 | 943 Million EUR | -8.17% |
| 2014 Q3 | 963.4 Million EUR | 2.16% |
| 2014 Q4 | 1 Billion EUR | 3.95% |
| 2014 FY | 1 Billion EUR | 2.3% |
| 2014 Q1 | 1.02 Billion EUR | 4.89% |
| 2013 Q2 | 887.7 Million EUR | -4.41% |
| 2013 Q1 | 928.7 Million EUR | 11.13% |
| 2013 FY | 979 Million EUR | 17.15% |
| 2013 Q4 | 979 Million EUR | 5.63% |
| 2013 Q3 | 926.8 Million EUR | 4.4% |
| 2012 Q3 | 791.9 Million EUR | 6.14% |
| 2012 Q2 | 746.1 Million EUR | -17.58% |
| 2012 Q1 | 905.2 Million EUR | 16.19% |
| 2012 FY | 835.7 Million EUR | 7.26% |
| 2012 Q4 | 835.7 Million EUR | 5.53% |
| 2011 Q2 | 668.5 Million EUR | -17.7% |
| 2011 Q3 | 706.9 Million EUR | 5.74% |
| 2011 Q4 | 779.1 Million EUR | 10.21% |
| 2011 Q1 | 812.3 Million EUR | 8.92% |
| 2011 FY | 779.1 Million EUR | 4.47% |
| 2010 FY | 745.8 Million EUR | 2.57% |
| 2010 Q3 | 693.8 Million EUR | 5.84% |
| 2010 Q4 | 745.8 Million EUR | 7.49% |
| 2010 Q1 | 771.8 Million EUR | 6.15% |
| 2010 Q2 | 655.5 Million EUR | -15.07% |
| 2009 FY | 727.1 Million EUR | 4.54% |
| 2009 Q4 | 727.1 Million EUR | 0.0% |
| 2008 FY | 695.5 Million EUR | 22.95% |
| 2007 FY | 565.7 Million EUR | -3.81% |
| 2006 Q4 | 588.1 Million EUR | 0.0% |
| 2006 FY | 588.1 Million EUR | -48.27% |
| 2005 FY | 1.13 Billion EUR | 0.11% |
| 2004 FY | 1.13 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AstraZeneca PLC | 100.97 Billion USD | 98.575% |
| Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | 98.488% |
| CSPC Pharmaceutical Group Limited | 6.52 Billion USD | 77.949% |
| Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -2682.161% |
| Novartis AG | 99.94 Billion USD | 98.561% |
| PT Kalbe Farma Tbk. | 1.75 Billion USD | 18.203% |